Your browser doesn't support javascript.
loading
Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome.
Agrawal, Vaibhav; Ranganath, Praveen; Ervin, Kirsten D; Schmidt, Caitlin A; Cox, Elizabeth A; Nelson, Robert P; Schwartz, Jennifer E; Zaid, Mohammad Abu; Abonour, Rafat; Robertson, Michael J; Brinda, Bryan J; Griffin, Shawn P; Thakrar, Teresa C; Farag, Sherif S.
Afiliación
  • Agrawal V; Department of Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Ranganath P; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Ervin KD; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Schmidt CA; Ascenssion Medical group, Anderson, IN, USA.
  • Cox EA; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Nelson RP; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Schwartz JE; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Zaid MA; Department of Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Abonour R; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Robertson MJ; Department of Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Brinda BJ; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Griffin SP; Department of Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Thakrar TC; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, IN, USA.
  • Farag SS; Department of Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
Bone Marrow Transplant ; 56(1): 121-128, 2021 01.
Article en En | MEDLINE | ID: mdl-32623447
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Veno-Oclusiva Hepática / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Veno-Oclusiva Hepática / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido